Andrew S. McCreath & Son, Inc. – Trademark Portfolio
Entity Type: 03
Andrew S. McCreath & Son, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 4 (Lubricants & Fuels) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include M, MCCREATH, and MCCREATH LABORATORIES. The owner is based in Harrisburg, PA.
P.O. Box 1453
236-242 Liberty St.
Harrisburg, PA 17105
Showing of trademarks Trademarks
Trademark Classifications
Andrew S. McCreath & Son, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does Andrew S. McCreath & Son, Inc. have?
Andrew S. McCreath & Son, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 cancelled.
What trademark classes does Andrew S. McCreath & Son, Inc. file in?
Andrew S. McCreath & Son, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 4 (Lubricants & Fuels). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Andrew S. McCreath & Son, Inc.'s most well-known trademarks?
Andrew S. McCreath & Son, Inc.'s registered trademark portfolio includes well-known marks such as M, MCCREATH, and MCCREATH LABORATORIES. These are among 3 currently registered trademarks in the portfolio.
What is Andrew S. McCreath & Son, Inc.'s trademark registration success rate?
Andrew S. McCreath & Son, Inc. has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.